2014
DOI: 10.1158/1055-9965.epi-13-0846
|View full text |Cite
|
Sign up to set email alerts
|

The Natural History of Cervical Cancer in Chinese Women: Results from an 11-Year Follow-Up Study in China Using a Multistate Model

Abstract: Background: It is important to understand the natural history of cervical cancer, which has implications for cancer prevention and management. However, a dearth of studies on the long-term development of cervical cancer exists in China.Methods: We investigated the natural history of cervical cancer in Chinese women by creating a multistate model using 11 years of follow-up data from the Shanxi Province Cervical Cancer Screening Study I conducted from 1999 to 2010. In 1999, a total of 1,997 eligible women, ages… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0
5

Year Published

2016
2016
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 47 publications
1
12
0
5
Order By: Relevance
“…And the positive rate of HPV 16/18 DNA was higher than that of E6 oncoprotein among CIN2/3, however, the disparity of positive rate between these two tests became tiny among cervical cancer patients. A retrospective study conducted in China found that no >20% CIN2 will progress to CIN3+ in 5 years without any intervention or treatment, which is consistent with other studies, and approximately 32% of CIN3 will progress to cancer in 30 years without treatment . In our study, the positive rate of OncoE6 for CIN2 and CIN3 was 13.2% and 44.0%, respectively, so we speculate the E6 positive CIN2 or CIN3 may have a higher risk to progress than negative ones, but no prospective studies have been done to directly prove this so far.…”
Section: Discussionsupporting
confidence: 88%
“…And the positive rate of HPV 16/18 DNA was higher than that of E6 oncoprotein among CIN2/3, however, the disparity of positive rate between these two tests became tiny among cervical cancer patients. A retrospective study conducted in China found that no >20% CIN2 will progress to CIN3+ in 5 years without any intervention or treatment, which is consistent with other studies, and approximately 32% of CIN3 will progress to cancer in 30 years without treatment . In our study, the positive rate of OncoE6 for CIN2 and CIN3 was 13.2% and 44.0%, respectively, so we speculate the E6 positive CIN2 or CIN3 may have a higher risk to progress than negative ones, but no prospective studies have been done to directly prove this so far.…”
Section: Discussionsupporting
confidence: 88%
“…The WHO suggested that a high screening coverage rate of 80% of the population at risk for cervical cancer was an important factor for a successful screening program . Unlike in developed countries, in China, approximately 75 500 patients are newly diagnosed with cervical cancer, with 34 000 deaths occurring every year . Cervical cancer is the fourth most frequent cancer in women and 90% of deaths occur in low‐ and middle‐income countries .…”
Section: Introductionmentioning
confidence: 99%
“…Neoadjuvant chemotherapy is important in cervical cancer treatment, since general chemotherapy drugs may promote tumor cell death by inducing cell apoptosis, but tend to induce drug resistance (2). Autophagy is a process of self-digestion by a cell through the action of enzymes originating within its lysosome of the same cell (3). Autophagy is often induced under conditions of stress that could also lead to cell death (4)(5)(6).…”
Section: Introductionmentioning
confidence: 99%